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Letter Regarding Article by Sega et al,
“Prognostic Value of Ambulatory and Home Blood
Pressures Compared With Office Blood Pressure
in the General Population”
To the Editor:
We read with interest the paper by Sega et al regarding the
prognostic value of ambulatory, home, and office blood pressure
in the PAMELA population.1 However, we find that the main
conclusions of the report may be driven by the lack of adjustment
for confounders. The relationships between level of blood
pressure and risk were not adjusted for age, which may have a
major influence on risk over a long time span. There is indeed a
relation between age and blood pressure,2 and therefore, these
results may be biased. The comparisons of the various blood
pressures were also not adjusted for potential confounders, with
the argument that “no adjustment for age, sex, and other
cardiovascular risk factors was made because comparisons be-
tween the predictive value of various blood pressure values
involved the same sample.” However, it has been shown in a
general Belgian population that the within-subject differences
between office and ambulatory blood pressure measurements
increased with older age and greater body mass index.3 In
addition, in the Danish MONICA population, the within-subject
differences between office and ambulatory blood pressure mea-
surements increased with older age, diagnosis of hypertension,
male gender, and presence of diabetes.4 So, to assess the true
prognostic value of office blood pressure versus that of ambula-
tory blood pressure, it is mandatory to explore whether adjust-
ments for other relevant cardiovascular risk factors would change
the results. Recently, it was shown in the Danish MONICA
population that ambulatory blood pressure was a much better
predictor of all-cause mortality and cardiovascular mortality than
office blood pressure, taking other relevant risk factors into
account.5
Accordingly, to make the results from previous studies com-
parable to the PAMELA study, we would like to know the results
of adjusted analyses. Until that time, the conclusion that “office,
home, and ambulatory blood pressures are similarly predictive of
the risk of cardiovascular and all-cause death” needs to be
interpreted with caution.
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To the Editor:
Sega and coworkers1 recently replicated the work of other
investigators.2,3 In Italians randomly recruited from the popula-
tion of Monza and enrolled in the Pressioni Arteriose Monitorate
e Loro Associazioni (PAMELA) study,1 they confirmed that
per mm Hg, the risk of all-cause and cardiovascular mortality
increased more with systolic than diastolic blood pressure (BP),
more with nighttime than daytime ambulatory BP, and more with
home or ambulatory than conventional BP measurement.
While confirmatory, the report by Sega et al leaves many
issues unaddressed. First, it deviates from current standards by
not accounting for sex, age, and other cardiovascular risk factors.
The authors argued that comparisons between the various types
of BP measurement involved the same subjects and confounding
factors; however, we previously demonstrated in 2 independent
populations that the parameters of the relations between BP and
age or body mass index significantly differed according to the
type of BP measurement.4 Thus, in Cox regression, the relative
hazard ratios associated with each type of BP measurement
might be substantially different depending on the inclusion of
other explanatory variables. For instance, in Belgian and Irish
subjects, the within-subject differences between office and am-
bulatory blood pressure measurements increased with age and
body mass index.4 Second, Sega et al presented the likelihood
ratio test statistic only for comparisons of various combinations
of systolic BP measurement in relation to cardiovascular mortal-
ity. They did not report these test statistics for comparisons
between the different types of BP measurement, between day-
time and nighttime BP, or between systolic and diastolic BP.
Third, over the last decennium, the introduction of invasive
therapies drastically reduced the case-fatality rate of major
cardiovascular complications, in particular those related to the
coronary complications of hypertension. The report by Sega et al
spans 10.9 years of follow-up that ended on December 31, 2003.
This probably explains why the 56 cardiovascular deaths only
represented 30.1% of all-cause mortality.1 Not accounting for
nonfatal events is important for the generalization of the results
of the study by Sega et al. Finally, in Figures 2, 3, and 4, Sega
and coworkers duplicated the unadjusted results already present-
ed in the continuous risk functions given in Figure 1. Because of
the low number of cardiovascular deaths, the vertical scale of the
Kaplan-Meier estimates only spanned 5%. Because these esti-
mates remained unadjusted for confounders, they cannot be
extrapolated to other populations with different age distribution
or cardiovascular risk profiles.
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To the Editor:
Sega and colleagues1 compared the prognostic value for
mortality risk of home and ambulatory blood pressure (BP)
measurement with office BP measurement in a Italian general
population using 11-year follow-up data from the Pressioni
Arteriose Monitorate e Loro Associazioni (PAMELA) study.
They reported that the overall ability to predict death was not
greater for home and ambulatory than for office BP
measurement.
In a Japanese general population (the Ohasama study), we
previously reported that the prognostic value of home and
ambulatory BP measurement was superior to office BP measure-
ment for mortality risk.2,3 More recently, using 10-year
follow-up data, we have demonstrated that home and ambulatory
BP measurement is also superior to office BP measurement in
predicting the risk of stroke.4,5
The mostly nonsignificant difference among predictive powers
of the 3 methods of BP measurement in the PAMELA study1
would be attributable to the smaller statistical power due to a
smaller number of events (56 cardiovascular deaths1) compared
with the recent data of the Ohasama study (136 fatal and nonfatal
stroke events4 and 152 composite events of cardiovascular death
and nonfatal stroke5). The less remarkable predictive power of
home BP in the study by Sega et al would also be attributable to
the smaller number of home BP measurements in the PAMELA
population (average of only 2 home BP values obtained in the
morning and in the evening within a day) compared with that
used in our Ohasama study (average of 21 home BP values),
because we demonstrated that the predictive power of home BP
measurement linearly increased with an increase in the number
of home BP measurements taken.4 The authors’ conclusions
from the PAMELA study should be interpreted with caution,
because their results might not be applicable to the predictive
power of home BP obtained by multiple self-measurements.
Comparison of the prognostic value of multiple self-
measurements of home BP and ambulatory BP awaits further
follow-up results from the Ohasama study.
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We read with interest the letters commenting on the results of
our study.1 Our reply to the remarks are as follows.
Home blood pressure (BP). Our data do not disagree with the
results of the Ohasama Study2 on the clinical importance of home
BP, because (1) the goodness-of-fit to the model predicting
cardiovascular or all-cause mortality was, if anything, higher
than that of office or 24-hour BP measurement; (2) this was the
case even if only 2 home BP measurements were available,
which did not allow us to fully explore the potentials of this
approach; and (3) combining office with home BP values
improved the predictive ability of the model.
Comparisons of statistical tests. The likelihood ratio test
cannot be used to compare differences in the goodness of fit
between different BPs. The question seems to us somewhat
irrelevant, however, because the goodness-of-fit values were not
lower for office than for ambulatory BP measurements,1 which
justifies our conclusion about the noninferiority of its prognostic
importance.
Adjustment for “confounders.” We decided (see Methods) not
to adjust for other variables because office, home, and ambula-
tory BPs were obtained at the same time in the same subjects, ie,
we dealt with a within-sample comparison that did not require
adjustments for differences that simply did not exist. Moreover,
in general, we are against the habit of drawing conclusions based
on extensive adjustment of original data because (1) this does not
guarantee that the role played by factors other than that under
study is eliminated, a goal that can be achieved, whenever
possible, by recollection of data devoid of the previously
observed differences, and (2) the statistical attempt to dissociate
the role of factors that are intimately related can be biologically
artificial and in some instances can distort the inherent features
of the phenomenon under study, thus introducing rather than
removing confounders. This applies to the increasing difference
between office and ambulatory or home BP with aging (reported
years ago in a PAMELA report3), which characterizes the overall
relationships and behavior of these pressures and thus must not
be arbitrarily corrected. The above does not exclude that other
factors can differently modify the effects of office, home, or
ambulatory blood pressure, eg, that gender, age, or blood glucose
interacts with office values differently than it does with ambu-
latory values. It also does not mean that the conclusion reached
for the whole population sample applies to all subsamples, eg,
old versus young subjects, males versus females, hypertensive
versus normotensive individuals; however, these are additional
issues that we did not address, also because of the limited number
of fatal events we could count on.
Novelty of data. It is somewhat contradictory to define the data
as “confirmatory” and at the same time disagree with their
conclusion. Our data confirm some previous results, often
obtained, however, in selected groups of subjects, and none of
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which had office, home, and ambulatory values all available. In
addition, the evidence comes from a large population and a very
long follow-up. Finally, much more than previous contributions,
the results emphasize the prognostic importance of office BP and
show the flatter slope of its relationship with events to be the
clearest prognostic difference from the other pressures.
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